{{$root.universalMessage.text}}

US Congress HR11617

A bill to amend the Federal Food, Drug, and Cosmetic Act to require the generic labeling of drugs and the disclosure to drug users of side effects, adverse reactions, and related information; to strengthen the records and reports authority under that act; to require the reporting of information respecting significant health hazards to authorize conditional approval of new drugs; to strengthen the Food and Drug Administration.